Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

3 Feb 2011 07:00

RNS Number : 5974A
Creston PLC
03 February 2011
 

 

 

 

 

3 February 2011

 

Creston plc

Interim Management Statement 

 

Creston plc ("Creston" or the "Group") (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 October 2010 to 2 February 2011.

Trading update

For the nine months to 31 December 2010, the Group reported like-for-like revenue growth of over 6%.

Following its excellent revenue growth in the first half, the Communications Division continued to record good growth in the third quarter, winning a global eCRM project from new client, Sony Ericsson, alongside new briefs from existing clients, including Danone and Tropicana. In addition to continuing the new business growth, the Communications Division is achieving its objective of improving the profit conversion and margin on the reported revenue growth.

The Health Division increased its rate of growth from the first half by winning a number of new briefs from current clients. In the period, the new consumer health start-up won a joint pitch with the Communications Division for the UK launch of Asanor, a new consumer healthcare product for snoring.

In the Insight Division, the focus has been on driving new business development and new product initiatives following the appointment of a new senior management team at ICM. In the new calendar year, there has been a notable increase in commissions at ICM. It has commenced a significant programme of consumer research for the recent new client Sainsbury's; the Electoral Reform Society, another new client, has commissioned a project to test voters' attitudes ahead of the forthcoming alternative vote referendum; and BT, an established client, has commissioned an extensive qualitative research study across Asia and North America.

Corporate development in the period

The acquisition of Cooney/Waters and Alembic Health Communications was approved by shareholders on 15 December and the acquisition completed on 20 December 2010. This acquisition extends the Health Division's international service of clients and provides an excellent platform to pitch for global projects. Since acquisition, the integration programme of Cooney/Waters and Alembic Health Communications into the Group has progressed well, trading has been in line with expectations and in January there was a successful joint new business pitch with our UK healthcare PR agency, Red Door Communications. 

Outlook

The fourth quarter is traditionally Creston's strongest, and with positive momentum across the Group, management's expectations for the full year remain unchanged.

 For further information, please contact:

Creston plc

020 7930 9757

Don Elgie, Chief Executive

 

Barrie Brien, COO/CFO

Sarah Macleod, Communications Director

 

www.creston.com

 

 About Creston plc

Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across the Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAPAAEFKFEFF
Date   Source Headline
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20252:09 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20254:04 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20254:47 pmRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20252:43 pmRNSHolding(s) in Company
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20255:42 pmRNSHolding(s) in Company
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSDirectorate Change
5th Nov 20257:00 amRNSTrading update for Q3 2025
4th Nov 20257:00 amRNSAppointment of Chief Underwriting Officer
22nd Oct 20257:00 amRNSNotice of Trading Update for Q3 2025
12th Aug 20254:31 pmRNSHolding(s) in Company
6th Aug 20254:50 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSInterim results for the six months ended 30/06/25
17th Jul 20257:00 amRNSNotice of Interim Results for 2025
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSHolding(s) in Company
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
20th May 20254:53 pmRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNS$50 million Share Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.